Hospital Wansiri
| Tailandia | España | Turquía | |
| Terapia con Actinio-225 | de $25,000 / 925,000฿ | de $45,000 / 1,665,000฿ | de $22,955 / 849,335฿ |
| Microcirugía de Mohs | de $2,200 / 81,400฿ | de $2,200 / 81,400฿ | de $2,200 / 81,400฿ |
| Inmunoterapia con Keytruda (Pembolizumab) | de $8,000 / 296,000฿ | de $15,000 / 555,000฿ | de $3,300 / 122,100฿ |
| Cirugía de melanoma | de $4,000 / 148,000฿ | de $4,500 / 166,500฿ | de $3,500 / 129,500฿ |
| Terapia tópica del melanoma | - | de $6,308 / 233,396฿ | de $1,450 / 53,650฿ |
Dr. Ohm Sudchumphae is a regenerative medicine specialist at Panacee Hospital Rama 2 in Bangkok. He holds a Master’s in Clinical Nutrition and Integrative Medicine. Dr. Ohm is currently pursuing a Doctorate in Psychology. He specializes in combining cell therapy, IV nutrition, and medicinal herbology for chronic conditions.
Escrito por Вероника Казина
El tratamiento del melanoma en Tailandia incluye la escisión local amplia, la cirugía de Mohs y la biopsia del ganglio centinela. Los centros internacionales ofrecen inmunoterapia avanzada utilizando inhibidores de PD-1 como Keytruda. También están disponibles terapias dirigidas para mutaciones BRAF y opciones basadas en células, como la terapia con células NK. La mayoría de los hospitales cuentan con la acreditación JCI.
Perspectiva del experto de Bookimed: La infraestructura de Tailandia permite transiciones rápidas entre el diagnóstico y el tratamiento. La mayoría de las clínicas acreditadas por la JCI en Bangkok completan las pruebas moleculares y la estadificación en 48 horas. Esta velocidad es vital para los casos de melanoma agresivo. Algunos centros también se especializan en combinar protocolos estándar con terapias regenerativas de células NK.
Consenso de los pacientes: Los pacientes destacan la rapidez de los resultados diagnósticos en comparación con sus países de origen. Muchos aprecian las explicaciones exhaustivas proporcionadas por los oncólogos sobre los efectos secundarios de la inmunoterapia.
Los hospitales tailandeses recomendados para el melanoma incluyen Bumrungrad International y Bangkok Hospital. Estas instalaciones cuentan con la acreditación de calidad de la Joint Commission International. Utilizan herramientas de diagnóstico avanzadas como escáneres PET-CT. Centros especializados como el Wattanosoth Cancer Hospital se centran exclusivamente en la investigación y atención oncológica.
Opinión experta de Bookimed: Los centros de oncología tailandeses a menudo albergan subcentros especializados para el cáncer de piel. Bumrungrad, por ejemplo, opera el Horizon Regional Cancer Center. Este enfoque dedicado conduce a mayores volúmenes de pacientes. Los médicos allí adquieren más experiencia con estadios complejos de melanoma. Elegir estas unidades especializadas garantiza el acceso a juntas multidisciplinarias de tumores.
Consenso de los pacientes: Los pacientes a menudo mencionan que el personal y los médicos son muy profesionales. Señalan que las instalaciones son limpias y modernas. Muchos aprecian la rapidez de las pruebas de diagnóstico en los hospitales de Bangkok. La atención personal de las enfermeras también destaca en sus reseñas.
La recuperación del melanoma en Tailandia suele durar de 1 a 3 semanas para la cicatrización primaria de la herida. La mayoría de los pacientes pueden volar a casa de forma segura entre 7 y 10 días después de la cirugía. Los viajes de larga distancia a menudo requieren esperar al menos 14 días para minimizar los riesgos de coágulos sanguíneos. Su cirujano debe proporcionarle un certificado de aptitud para volar.
Perspectiva del experto de Bookimed: Los centros oncológicos tailandeses como Bumrungrad o el Bangkok Hospital a menudo coordinan revisiones multidisciplinarias en un plazo de 48 horas. Esta eficiencia ayuda a los pacientes internacionales a comenzar la recuperación antes. Nuestros datos muestran que los centros de alto volumen priorizan la movilidad temprana para los viajeros. Este enfoque ayuda a mantener una tasa del 95% de salidas sin complicaciones.
Consenso de los pacientes: Los pacientes señalan que es vital permanecer cerca de la clínica durante la primera semana. A menudo enfatizan que controlar la hinchazón es el mayor desafío durante el vuelo de regreso a casa.
Melanoma treatment in Thailand includes surgical excision, immunotherapy with PD-1 inhibitors like Keytruda, and Mohs microsurgery. JCI-accredited hospitals in Bangkok provide these therapies. They also offer Natural Killer (NK) cell therapy and targeted radiopharmaceutical treatments. Centres like Bumrungrad International Hospital often complete staging and molecular testing within 48 hours.
Bookimed Expert Insight: Many Australian patients seek standard surgery, but Thailand offers integrated care. Bumrungrad International Hospital treats over 1,000,000 patients annually. It maintains GHA and JCI accreditations. This high volume allows clinics to offer niche treatments like Natural Killer cell therapy. This combination is rare in smaller regional centres and helps with complex cases.
Patient Consensus: Patients note that prompt specialist assessment and accurate pathology reviews are vital. They highlight the importance of multidisciplinary teams. It is also important to have clear follow-up plans for when they return home.
Specialised immunotherapy and targeted melanoma treatments are widely available in Thailand. Leading Bangkok hospitals offer options like Keytruda and BRAF mutation testing. These facilities maintain high standards through JCI and ISO certifications. This means patients receive care comparable to Australian private hospitals.
Bookimed Expert Insight: While many centres treat general oncology, Bumrungrad International Hospital manages over 1,000,000 patients annually. This massive volume includes international patients from 190 countries. Their experience with complex foreign cases often means smoother logistics for Australians. This includes easier access to English-speaking specialists and streamlined medical records.
Patient Consensus: Patients note that Thailand provides faster access to treatment than many public systems. They suggest confirming specific drug stock and mutation testing availability before flying to Bangkok.
Mohs micrographic surgery is available in Thailand at specialised tertiary hospitals and cancer centres. Fellowship-trained surgeons perform this precise procedure. It reports success rates of 97% to 99%. It remains a primary choice for high-risk melanoma and delicate areas like the face.
Bookimed Expert Insight: Thailand ranks 4th globally for international patient requests in our database. Major hospitals like Bumrungrad International serve 190 countries and prioritise digital health records. This infrastructure helps Australian patients receive seamless follow-up care with their local GP.
Patient Consensus: Patients note it is important to confirm if a clinic uses frozen-section Mohs or staged excision. They suggest getting a written plan covering margin control and pathology before travelling to Thailand.
Melanoma treatment in Thailand typically begins within a few days to two weeks of diagnosis. Hospitals like Bumrungrad International provide molecular testing and staging within 48 hours. This efficiency allows surgeons and oncologists to finalise treatment plans and schedule theatre time almost immediately.
Bookimed Expert Insight: Thailand leads in rapid oncology onboarding. Major centres like Bumrungrad International have 1,300 doctors on-site. This scale eliminates the long waiting lists common in Australia. Patients can often start immunotherapy or surgery in under 5 days if pathology slides are ready.
Patient Consensus: Patients note that bringing original pathology slides and imaging reports from Australia speeds up the process. Same-day specialist consults in Bangkok are common. However, hospitals often require upfront deposits before booking surgery or targeted therapies.
Patients can get a second opinion for melanoma in Thailand at JCI-accredited centres. Specialists offer expert reviews of pathology slides, BRAF gene testing, and staging. Many clinics provide remote consultations. This allows Australians to access oncology expertise and immunotherapy protocols before travelling for treatment.
Bookimed Expert Insight: Thailand ranks 4th globally for patient requests. Bumrungrad International Hospital alone serves 1,000,000 patients annually. This massive volume means Thai oncologists see many advanced melanoma cases. For Australians, this scale helps build expertise in rare or resistant melanoma subtypes.
Patient Consensus: Patients note it is important to request a review of both diagnosis and staging. They recommend bringing pathology slides to Thailand for an independent assessment by a surgical oncologist.
Thailand serves over 1 million international patients annually with melanoma care through JCI-accredited hospitals. Specialist centres provide multidisciplinary treatment including Mohs microsurgery and PET-CT diagnostics. They also offer modern immunotherapies like Keytruda. These facilities use tumour boards to coordinate surgical oncology and pathology services for precise results.
Bookimed Expert Insight: Many Australian patients focus only on major surgical hubs. However, integrative centres like Panacee Hospital Rama 2 offer alternative supportive therapies. These include Oncothermia and cell-based treatments. Combining these with surgery at major Bangkok facilities creates a comprehensive recovery plan. This dual approach helps manage complex stages that standard protocols might not address alone.
Patient Consensus: Patients find it essential to choose hospitals with dedicated oncology teams. They advise against using cosmetic dermatology clinics for melanoma care. Experience shows that checking for in-house histopathology review is vital. Patients also suggest checking that imaging can be sent to Australia for follow-up.